Skip to Main Content

Author Details

Raphaela Schwentner
Children's Cancer Research Institute
2008
26
18
PMIDPaper TitleJournal TitlePublished Year
33419969YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells.Oncogenesis2021
33419969YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells.Oncogenesis2021
32497717Assessment of Pre-Analytical Sample Handling Conditions for Comprehensive Liquid Biopsy Analysis.J Mol Diagn2020
32497717Assessment of Pre-Analytical Sample Handling Conditions for Comprehensive Liquid Biopsy Analysis.J Mol Diagn2020
30474648Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis.Pediatr Res2019
30296338JAG2 signaling induces differentiation of CD14<sup>+</sup> monocytes into Langerhans cell histiocytosis-like cells.J Leukoc Biol2019
30474648Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis.Pediatr Res2019
31345789Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis.Cancer Discov2019
31345789Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis.Cancer Discov2019
30296338JAG2 signaling induces differentiation of CD14<sup>+</sup> monocytes into Langerhans cell histiocytosis-like cells.J Leukoc Biol2019
29774135Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature.Oncotarget2018
30123424Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers.Oncotarget2018
29774135Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature.Oncotarget2018
30123424Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers.Oncotarget2018
28030800The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma.Oncotarget2017
28691904Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts.Elife2017
28671673EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma.Oncogene2017
29296950Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH.Blood Adv2017
28030800The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma.Oncotarget2017
28160567EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells.Oncotarget2017
28160567EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells.Oncotarget2017
29296950Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH.Blood Adv2017
28671673EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma.Oncogene2017
28691904Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts.Elife2017
27282934EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway.FEBS Lett2016
27282934EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway.FEBS Lett2016
25712098EWS-FLI1 employs an E2F switch to drive target gene expression.Nucleic Acids Res2015
25712098EWS-FLI1 employs an E2F switch to drive target gene expression.Nucleic Acids Res2015
23995784Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma.Oncogene2014
25281719Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma.Cancer Res2014
25625846Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.Epigenetics2014
23995784Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma.Oncogene2014
25625846Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.Epigenetics2014
25281719Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma.Cancer Res2014
23940108Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer.Genome Res2013
23940108Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer.Genome Res2013
24129240Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma.Br J Cancer2013
24129240Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma.Br J Cancer2013
22662320The first European interdisciplinary ewing sarcoma research summit.Front Oncol2012
22662320The first European interdisciplinary ewing sarcoma research summit.Front Oncol2012
23074278Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells.Blood2012
23074278Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells.Blood2012
21217773Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma.Oncogene2011
21217773Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma.Oncogene2011
22135504Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma.Sarcoma2011
22135504Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma.Sarcoma2011
20200493miRNA, siRNA, piRNA and argonautes: news in small matters.RNA Biol2010
20442286Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro.Cancer Res2010
20200493miRNA, siRNA, piRNA and argonautes: news in small matters.RNA Biol2010
20442286Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro.Cancer Res2010
  • 1 - 50 of 52

Recommended Authors

Tuo Zhang
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
Florencia Cidre-Aranaz
Hopp-Children's Cancer Center (KiTZ)
Career Start Year 2011
Number of shared co-authors 28
Samuel J Shelton
University of California san francisco
Career Start Year 2011
Number of shared co-authors 0
Rahul K Kollipara
McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 0
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Richard Mitter
The Francis Crick Institute
Career Start Year 2008
Number of shared co-authors 1
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 1
Thomas G P Gr??newald
German Cancer Research Center
Career Start Year 2006
Number of shared co-authors 30
Joshua J Waterfall
INSERM U, PSL Research University, Institut Curie Research Center
Career Start Year 2006
Number of shared co-authors 8
Richard Koche
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 2
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 1
Didier Surdez
Balgrist University Hospital, University of Zurich (UZH)
Career Start Year 2005
Number of shared co-authors 32
Antonio Sorrentino
Leibniz Institute for Immunotherapy (LIT)
Career Start Year 2005
Number of shared co-authors 0
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 0
Michele Ceribelli
National Center for Advancing Translational Sciences
Career Start Year 2004
Number of shared co-authors 1
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 0
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 0
Joyce E Ohm
Roswell Park Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 10
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 10
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 6
Kimberly Stegmaier
Dana-Farber Cancer Institute
Career Start Year 1995
Number of shared co-authors 28
Wenbin Wei
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 1991
Number of shared co-authors 1
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 3

Collaborators

Heinrich Kovar
St. Anna Children's Cancer Research Institute (CCRI), Medical University Vienna
Co-authored papers 18
Maximilian Kauer
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 16
Gunhild Jug
Children's Cancer Research Institute
Co-authored papers 8
Jozef Ban
Children's Cancer Research Institute
Co-authored papers 8
Caroline Hutter
Children's Cancer Research Institute, Medical University of Vienna
Co-authored papers 7
Reinhard Kofler
Medical University of Innsbruck
Co-authored papers 3
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Wolfgang Holter
St. Anna Children's Hospital, Medical University of Vienna
Co-authored papers 3
Elizabeth R Lawlor
Seattle Children's Research Institute
Co-authored papers 3
Katia Scotlandi
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 3
Sven Bilke
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Fan Yang
West China Second Hospital, Sichuan University
Co-authored papers 2
Jeffrey A Toretsky
Georgetown University Medical Center, Georgetown University
Co-authored papers 2
Beat W Sch??fer
Department of Oncology and Children's Research Center, University Children's Hospital
Co-authored papers 2
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Eleni M Tomazou
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 2
Udo Kontny
Co-authored papers 2
Branka Radic-Sarikas
St. Anna Children's Cancer Research Institute (CCRI), Medical University of Vienna
Co-authored papers 2
Sabine Taschner-Mandl
St. Anna Children's Cancer Research Institute
Co-authored papers 1
René Geyeregger
Co-authored papers 1
Stefan Burdach
Technische Universitat Munchen
Co-authored papers 1
Pieter Mestdagh
Co-authored papers 1
B. E. Snaar-Jagalska
Institute of Biology, Leiden University
Co-authored papers 1
Olivier Delattre
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers 1
Matthias Farlik
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
Claudia Rossig
University Children's Hospital Muenster
Co-authored papers 1
Markus Metzler
University Hospital Erlangen
Co-authored papers 1
Stephen L Lessnick
The Ohio State University College of Medicine
Co-authored papers 1
Franck Tirode
Cancer Center of Lyon
Co-authored papers 1
Jo Vandesompele
Co-authored papers 1
Release 1.2